Drucker Wealth 3.0 LLC boosted its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 130.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 5,054 shares of the financial services provider’s stock after acquiring an additional 2,863 shares during the period. Drucker Wealth 3.0 LLC’s holdings in CME Group were worth $1,365,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. Amundi increased its stake in CME Group by 24.0% in the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after buying an additional 385,225 shares during the last quarter. Truist Financial Corp grew its holdings in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after acquiring an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC grew its holdings in shares of CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after acquiring an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC increased its position in shares of CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after acquiring an additional 3,919 shares during the last quarter. Finally, Victory Financial Group LLC lifted its holdings in CME Group by 310.2% during the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after acquiring an additional 2,302 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.
Insider Activity
In other CME Group news, Director Dennis Suskind sold 748 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director directly owned 2,699 shares in the company, valued at $809,700. This represents a 21.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.
CME Group Stock Up 0.1%
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.52 earnings per share. On average, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is presently 46.59%.
Wall Street Analysts Forecast Growth
CME has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upped their price objective on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research note on Thursday, February 5th. Piper Sandler increased their price target on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Morgan Stanley raised their price objective on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Rothschild & Co Redburn boosted their target price on shares of CME Group from $300.00 to $333.00 and gave the company a “neutral” rating in a research note on Thursday, February 12th. Finally, Royal Bank Of Canada raised their price target on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 5th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $299.53.
Get Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Energy Security Is Now National Security – Positioning Is Happening Now
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
- How to collect $1,170 a month from silver
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
